- Serbia enters New Year with student protests over train station tragedy
- Romania, Bulgaria join borderless Schengen zone
- US Capitol riot fugitive seeks asylum in Canada
- Musk flummoxes internet with 'Kekius Maximus' persona
- US stocks slip as European markets ring out year with gains
- Olmo's Barcelona future in air over registration race
- Venezuela opposition urges protests against Maduro's inauguration
- Syria's de facto leader meets minority Christians
- Suriname ex-dictator Bouterse to be cremated on Saturday
- £1.5 mn reward offered after 'brazen' London gem raid
- Zimbabwe abolishes the death penalty
- Barcelona race against clock to register Olmo
- Arteta wants Arsenal to hammer away in title race
- Panama marks canal handover anniversary in shadow of Trump threat
- Gaza hospital chief held by Israel becomes face of crumbling healthcare
- Russian advances in Ukraine grew seven-fold in 2024, data shows
- US, European stock markets look to ring out year with gains
- US farmers fret over Trump's deportation plans
- BBC celebrates 100 years of 'poetic' shipping forecast
- West Ham's Bowen sidelined with foot fracture
- Global markets rode AI, interest rate roller coaster in 2024
- Ocalan: PKK chief held in solitary on Turkish prison island
- European stock markets end year with gains
- Yemen's Huthis a 'menace' for Israel despite weakened Iran: analysts
- Rooney exit extends managerial struggles for England's 'golden generation'
- Gaza healthcare nearing 'total collapse' due to Israeli strikes: UN
- German leaders hit back at Musk's support for far right
- Southgate won't be 'Sir' at home after knighthood
- Rooney leaves Plymouth after just seven months in charge
- Kyrgios needs 'miracle' after return from long injury layoff
- Raducanu pulls out of Australian Open warm-up with back problem
- Celebrated S.African contemporary dancer Dada Masilo dies aged 39
- Five talking points at the midway point of the Premier League season
- Angelina Jolie and Brad Pitt reach divorce settlement
- Djokovic, Sabalenka win season-openers but Kyrgios loses on return
- Taiwan says 2024 was hottest year on record
- China says shared Covid information 'without holding anything back'
- Kyrgios goes down fighting on return, Sabalenka wins season-opener
- Xi says China must apply 'more proactive' macroeconomic policies in 2025
- Gauff, Paolini on fire as USA, Italy surge into United Cup quarters
- Patients brave mental health desert in Mauritania
- Hart triple-double sparks Knicks to eighth straight NBA win
- Angelina Jolie and Brad Pitt reach divorce settlement: report
- Sabalenka opens season with 'tricky' win in Brisbane
- S. Korea starts releasing Jeju Air crash victims to families
- China's frigid northeast thrives on 'little potato' tourism boom
- Paolini on fire as Italy surge into United Cup quarter-finals
- Hart's triple double sparks Knicks to eighth straight NBA win
- Asian stocks dip as Santa snubs Wall Street
- World greets 2025 after sweltering year of Olympics, turmoil, and Trump
Brazil's banana spider aids erectile dysfunction treatment
Three decades ago, Brazilian researchers began studying a curious side effect from banana spider bites: the toxin left victims with priapism, a painful and persistent erection.
The scientists were inspired to develop a synthetic molecule using some properties of the spider's poison to create a gel to treat erectile dysfunction, which is now undergoing promising clinical trials.
Covered in thick brown hair, and with a maximum size of up to 15 centimeters (six inches), the arachnid is one of the most poisonous in the world.
It is found in several South American countries, and was nicknamed for its common presence in banana plantations, but it is also called the "wandering spider" or "armed spider."
In the southeastern Brazilian state of Minas Gerais, it is found in rural areas as well as urban centers.
At the Ezequiel Dias Foundation (FUNED), a medical research center in the state's capital Belo Horizonte, a biologist delicately grabs one of the spiders with a pair of tweezers and stimulates its fangs to get a few drops of venom.
FUNED then sends the venom to the Federal University of Minas Gerais (UFMG) which has been researching which component could be replicated to treat erectile dysfunction, which affects tens of millions of men around the world.
"The venom is only used to learn the properties of the molecule" which causes the priapism in bite victims, said Maria Elena de Lima, a UFMG researcher.
Brazilian biotech company Biozeus has bought the patent for the molecule.
The company wants to sell it in an ointment, which would be rubbed on the penis when required, resulting in an erection in a few minutes, said de Lima.
The molecule triggers the release of nitric oxide, which is essential for an erection as it increases blood circulation and allows blood vessels to widen.
De Lima said the research could be especially useful in the fight against cancer, as men suffering prostate cancer often refuse a procedure to remove the prostate because it can damage nerves and lead to erectile dysfunction.
After the first phase of clinical trials was approved by Brazil's Anvisa regulatory agency, the medication has now moved into the second of three phases prior to being approved for sale.
De Lima said the discovery of a potential erectile dysfunction treatment was a message "not to destroy animals, even poisonous ones, because there is a real library of molecules that are still unknown."
C.Garcia--AMWN